Skip to main content
Fig. 4 | Cardiovascular Diabetology

Fig. 4

From: Countering adipose tissue dysfunction could underlie the superiority of telmisartan in the treatment of obesity-related hypertension

Fig. 4

Anti-inflammatory and antioxidative stress effects of telmisartan in diet-induced obesity hypertension. a Serum high sensitivity C reactive protein level in control, DIO and DIO + Tel groups. b Serum tumour necrosis factor alpha level in control, DIO and DIO + Tel groups. c Serum interleukin 6 level in control, DIO and DIO + Tel groups. d Serum superoxide dismutase level in control, DIO and DIO + Tel groups. e Serum nitric oxide level in control, DIO and DIO + Tel groups. f Serum malondialdehyde level in control, DIO and DIO + Tel groups (number of rats = 10/group. P < 0.05 considered significant, * significant when compared to the control group, • significant when compared to the DIO group)

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840